WJA
FBRX icon

Williams Jones & Associates’s Forte Biosciences FBRX Stock Holding History

Williams Jones & Associates’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-37
Closed -$115K – 412
2018
Q4 		$115K Hold
37
– – ﹤0.01% 370
2018
Q3 		$218K Sell
37
-4
-10% -$15.2K ﹤0.01% 400
2018
Q2 		$145K Sell
41
-6
-13% -$22K ﹤0.01% 419
2018
Q1 		$207K Hold
47
– – ﹤0.01% 407
2017
Q4 		$179K Buy
47
+7
+18% +$27.9K ﹤0.01% 412
2017
Q3 		$187K Buy
+40
New +$178K ﹤0.01% 406

Other funds holding FBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Williams Jones & Associates's FBRX Position: Q1 2019 in Review

Williams Jones & Associates sold out of Forte Biosciences (FBRX) in Q1 2019, closing a stake of 37 shares — an estimated $115K sold.

Williams Jones & Associates first reported a position in FBRX in Q3 2017 and held it in 6 quarters. The position peaked at $218K in Q3 2018. 78 funds tracked by Wall St. Rank hold FBRX as of Q1 2019.

  • Williams Jones & Associates reported no remaining Forte Biosciences position as of Q1 2019 after selling out during the quarter.
  • Williams Jones & Associates sold 37 Forte Biosciences shares in Q1 2019, an estimated $115K.
  • Williams Jones & Associates first reported a position in Forte Biosciences in Q3 2017 and held it in 6 quarters.
  • Williams Jones & Associates's Forte Biosciences position peaked at $218K in Q3 2018.
  • 78 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2019.

Based on Williams Jones & Associates's 13F filing for Q1 2019, filed 14 May 2019.